The News Review:
- Veeda ncology acquires Biologie et Industrie
- S$25m research project to identify risk factors for schizophrenia
- $10bn added to health infrastructure
- New MRI Technique Detects Subtle But Serious Brain Injury
- Healthy Skin – Avoiding Wrinkles – New York Times
- Applied Biosystems and Christian-Albrechts University Win Bio-IT…
Veeda ncology acquires Biologie et Industrie
Economic Times – May 13, 2008
“The acquisitionof Biologie et Industrie is one significant pillar that we are adding to ourglobal oncology presence within the oncology clinical research organisationmarketplace” Veeda Group Co-Managing Director Binoy Gardi said in a statementhere today. Biologie et Industrie has over 20 years of experience inoncology clinical research. “The clients of Biologie et Industriewill now be able to enjoy the strong global oncology patient accrual abilitythat currently exists within Veeda ncology as well as the other full servicecapabilities that Veeda ncology provides to their clients” he said. Veeda ncology provides clinical research trials with operations inIndia Eastern Europe Western Europe and the US.
S$25m research project to identify risk factors for schizophrenia
Channel News Asia – May 13, 2008
The study is part of a S$25 million programme to identify genetic biological and social risk factors for schizophrenia. ther parts of the programme include identifying genes that cause schizophrenia and a drug trial on new treatment to improve patients’ functional skills. The study is one of two projects awarded the Translational and Clinical Research Flagship Programme this year. The two research programmes were selected from eight submissions and were chosen based on their scientific merit the strength of the research teams and their relevance to Singapore. The other S$25 million project led by the Singapore Eye Research Institute focuses on glaucoma and corneal diseases – the leading causes of blindness in Singapore. The Singapore National Eye Centre treats over 34000 cases of glaucoma and 15000 patients with corneal diseases every year. Professor Donald Tan director of Singapore Eye Research Institute said: “We have very little understanding or ability to modulate wound healing.
$10bn added to health infrastructure
The Australian – May 13, 2008
5billion Health and Medical Infrastructure Fund which was to be supplemented by proceeds from the sale of the publicly owned Medibank Private. Federal Health Minister Nicola Roxon said the fund – which will finance new hospital and medical facilities equipment and technology – was the "biggest single investment in health infrastructure ever made by an Australian government". The money will also go towards medical research including projects and facilities that support better links between hospital-based clinical research and high-quality clinical practice. The Rudd Government has inherited a number of investment funds from its predecessor including the Future Fund and the Higher Education Endowment Fund rebadging them in the process. Ahead of last year’s election Labor promised to at least match the Howard government’s Health and Medical Infrastructure Fund without assigning a final figure to its promise. The decision to allocate $10billion to the purpose "demonstrates the Government’s commitment in partnership with state and territory governments to equip Australia’s health and hospital system for the future" Ms Roxon said. The $10billion will be drawn from the 2007-08 and 2008-09 budget surpluses with a share of future surpluses allocated to the fund "as appropriate".
New MRI Technique Detects Subtle But Serious Brain Injury
Science Daily – Science Daily (press release) – May 13, 2008
Christopher Madden assistant professor of neurological surgery; Dr. Carlos Marquez de la Plata assistant professor of psychiatry; Drs. Anthony Whittemore and Evelyn Babcock both assistant professors of radiology; Carol Moore and Kan Ding both clinical research coordinators in neurology; and medical students Tiffany Rickbeil Julia Dobervich David Kroll Bao Dao and Nisha Mohindra. Lead author Jun-Yi Wang; Dr. Khamid Bakhadirov; and Dr. Herve Abdi from the department of cognition and neuroscience at UT Dallas also participated in the study. The work was supported by the National Institute on Disability and Rehabilitation Research and the National Institutes of Health.
Healthy Skin – Avoiding Wrinkles – New York Times
New York Times – May 13, 2008
Some of the following advice is backed by independent clinical research while other practical tips come from board-certified dermatologists. “I’m big on simplifying everything” said Dr. Dover an associate clinical professor of dermatology at.
Applied Biosystems and Christian-Albrechts University Win Bio-IT…
Earthtimes – May 13, 2008
- (Business Wire) The editors of Bio-IT World honored Applied Biosystems (NYSE:ABI) an Applera Corporation business and Christian-Albrechts University with a Bio-IT World 2008 Best Practices Award for “Basic Research R&D. ” This award recognizes the achievement of researchers from the University Hospital of the Christian-Albrechts University in Kiel Germany and Applied Biosystems who developed methods and a best practice that led to the identification of a novel genetic variant in a gene not previously associated with Crohn’s disease a complex disorder characterized by chronic inflammation of the digestive tract. Bio-IT World’s Best Practices Award Program which was established in 2003 recognizes teams for their novel and innovative use of technology to improve the efficiency and economics of R&D drug discovery and clinical research and trials. The award program is meant to bring broader awareness to the life science field’s most innovative best practices and encourage the sharing of information among the scientific community. “The quality and breadth of the 2008 Best Practices Award competition surpassed all expectations” said John Russell executive editor of Bio-IT World. “Applied Biosystems and Christian-Albrechts University were recognized as one of the grand prize winners for developing an innovative pipeline for the identification of common susceptibility variants of functional significance for diseases. ” The research team tested DNA samples from patients with Crohn’s disease compared with normal DNA samples using the Applied Biosystems SNPlex™ Genotyping System.
